1. Home
  2. HUBC vs MBRX Comparison

HUBC vs MBRX Comparison

Compare HUBC & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
  • MBRX
  • Stock Information
  • Founded
  • HUBC 2017
  • MBRX 2015
  • Country
  • HUBC Israel
  • MBRX United States
  • Employees
  • HUBC N/A
  • MBRX N/A
  • Industry
  • HUBC
  • MBRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBC
  • MBRX Health Care
  • Exchange
  • HUBC Nasdaq
  • MBRX Nasdaq
  • Market Cap
  • HUBC 25.1M
  • MBRX 24.3M
  • IPO Year
  • HUBC N/A
  • MBRX 2016
  • Fundamental
  • Price
  • HUBC $1.62
  • MBRX $0.51
  • Analyst Decision
  • HUBC
  • MBRX Strong Buy
  • Analyst Count
  • HUBC 0
  • MBRX 4
  • Target Price
  • HUBC N/A
  • MBRX $5.00
  • AVG Volume (30 Days)
  • HUBC 631.2K
  • MBRX 2.7M
  • Earning Date
  • HUBC 11-11-2025
  • MBRX 11-07-2025
  • Dividend Yield
  • HUBC N/A
  • MBRX N/A
  • EPS Growth
  • HUBC N/A
  • MBRX N/A
  • EPS
  • HUBC N/A
  • MBRX N/A
  • Revenue
  • HUBC $29,562,000.00
  • MBRX N/A
  • Revenue This Year
  • HUBC N/A
  • MBRX N/A
  • Revenue Next Year
  • HUBC N/A
  • MBRX N/A
  • P/E Ratio
  • HUBC N/A
  • MBRX N/A
  • Revenue Growth
  • HUBC N/A
  • MBRX N/A
  • 52 Week Low
  • HUBC $1.62
  • MBRX $0.25
  • 52 Week High
  • HUBC $14.00
  • MBRX $3.65
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 34.01
  • MBRX 53.09
  • Support Level
  • HUBC $1.93
  • MBRX $0.42
  • Resistance Level
  • HUBC $2.10
  • MBRX $0.50
  • Average True Range (ATR)
  • HUBC 0.15
  • MBRX 0.04
  • MACD
  • HUBC -0.02
  • MBRX 0.01
  • Stochastic Oscillator
  • HUBC 1.67
  • MBRX 57.02

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Share on Social Networks: